DUBLIN--(BUSINESS WIRE)--The "Global Human Microbiome Market Analysis 2021-2031" report has been added to ResearchAndMarkets.com's offering.
The global human microbiome market is anticipated to grow with a CAGR of 22.3% over the forecast period, i.e., 2022 - 2031.
Factors such as the growing focus on microbiome therapeutics, followed by the surge in prevalence of lifestyle-related diseases, and the increasing research and developments on human microbiome are projected to add to the growth of the market in the coming years. The market is estimated to garner a revenue of near to USD 3250 Million by the end of 2031, up from a revenue of close to USD 440 Million in the year 2021.
The global human microbiome market is segmented by numerous segments which include segmentation by product, disease type, organism type, application, technology, and by region. By product, the market is segmented into probiotics, prebiotics, diagnostic tests, drugs, and others. By the end of 2031, the probiotics segment is anticipated to garner the largest revenue of about USD 1430 Million by the end of 2031. Additionally, in the year 2021, the segment generated a revenue of around USD 190 Million.
On the basis of regional analysis, the global human microbiome market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market in North America, out of the market in all the other regions, is anticipated to garner the largest revenue of near to USD 1860 Million by the end of 2031. Additionally, in the year 2021, the market in the region generated a revenue of more than USD 250 Million.
However, the stringent government regulations is expected to operate as key restraint to the growth of global human microbiome market over the forecast period.
Companies Mentioned
- Seres Therapeutics Inc.
- Evelo Biosciences Inc.
- Synlogic
- SECOND GENOME
- Synthetic Biologics Inc.
- YSOPIA Bioscience
- 4D pharma plc
- DuPont de Nemours Inc.
- BiomX Inc.
- Sun Genomics Inc.
- Viome Life Sciences Inc.
Key Topics Covered:
1. Market Definition
2. Assumptions & Acronyms
3. Research Methodology
4. Executive Summary
5. Market Dynamics
6. Value Chain Analysis
7. Regulatory & Standards Landscape
8. Industry Risk Analysis
9. Impact of COVID-19 on the Human Microbiome Market
10. Analysis of Upcoming Human Microbiome Projects
11. Analysis of Therapeutic Products
11.1. Product Type
11.2. Pros
11.3. Cons
12. Pipeline Analysis
13. Analysis on Skin Microbiome-Focused Products
14. Product Feature Analysis
15. Competitive Landscape
16. Global Human Microbiome Market
17. North America Human Microbiome Market
18. Europe Human Microbiome Market
19. Asia Pacific Human Microbiome Market
20. Latin America Human Microbiome Market
21. Middle East & Africa Human Microbiome Market
For more information about this report visit
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
